Skip to main content
OpenTrials
Recruiting

NCT Number: NCT01277419

German Spondyloarthritis Inception Cohort

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA) Acute Anterior Uveitis (AAU) Ankylosis Arthritis Axial Psoriatic Arthritis (axPsA) Axial Spondyloarthritis Bone Diseases Colitis Colitis, Ulcerative Colonic Diseases Crohn Disease Crohn Disease (CD) Digestive System Diseases Eye Diseases Gastroenteritis Gastrointestinal Diseases Inflammatory Bowel Diseases Intestinal Diseases Joint Diseases Musculoskeletal Diseases Non-Radiographic Axial Spondyloarthritis Non-radiographic Axial Spondyloarthritis (Nr-axSpA) Panuveitis Spinal Diseases Spondylarthritis Spondylarthropathies Spondylitis Spondylitis, Ankylosing Ulcerative Colitis (UC) Uveal Diseases Uveitis Uveitis, Anterior

Sex eligibility

All sexes

Study type

Observational

Primary location

Charité - Universitätsmedizin Berlin

Berlin, Germany

Location status: Recruiting

Location contact

Claudia Lorenz

CONTACT

[email protected]

Judith Rademacher, Dr.

PRINCIPAL_INVESTIGATOR

Mikhail Protopopov, Dr.

SUB_INVESTIGATOR

Murat Torgutalp, Dr.

SUB_INVESTIGATOR

Valeria Rios Rodriguez

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Main inclusion Criteria:

  • Patients with definite diagnosis of axial spondyloarthritis or juvenile spondyloarthritis.
  • Patients with definite diagnosis of Crohn's disease.
  • Patients with definite diagnosis of acute anterior uveitis.
  • Patients with definite diagnosis of psoriatic arthritis with axial involvement.

Study contacts

Contact information is provided by the study sponsor or research team.

Denis Poddubnyy, Prof. Dr.

CONTACT

[email protected]

+4930450514582

Sponsors and collaborators

Lead sponsor

Charite University, Berlin, Germany

Other

Collaborators

  • AbbVie
  • Amgen
  • Berlin Institute of Health
  • Centocor, Inc.
  • German Federal Ministry of Education and Research
  • Novartis
  • Schering-Plough
  • UCB Pharma
  • Wyeth is now a wholly owned subsidiary of Pfizer

Registry information

Acronym: GESPIC

Important dates

Study start
2000
Primary completion
2030
Study completion
2030
First posted
Jan 17, 2011
Registry last updated
Oct 12, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.